U.S. federal trademark · Serial No. 75880077
Topical and oral pharmaceutical compositions for the treatment of herpes virus related infections including but not limited to herpes simplex 1 (cold sores), herpes simplex 2 (genital herpes), herpes zoster (shingles), Cytomegalovirus, Epstein Barr Virus (chronic fatigue syndrome), herpes virus 6 (multiple sclerosis), herpes virus 7 and herpes virus 8 (Kaposi's Sarcoma)
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.